Analysis reveals rise in claim denial rates for cancer-related advanced genetic testing
Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national coverage determination ...
Apr 18, 2025
0
31









